Chou, P.-Y.; Lee, D.; Weng, C.-C.; Wu, R.-C.; Liao, C.-T.; Liu, S.-J.
Bone Morphogenetic Protein-, Antimicrobial Agent-, and Analgesic-Incorporated Nanofibrous Scaffolds for the Therapy of Alveolar Clefts. Pharmaceutics 2022, 14, 374.
https://doi.org/10.3390/pharmaceutics14020374
AMA Style
Chou P-Y, Lee D, Weng C-C, Wu R-C, Liao C-T, Liu S-J.
Bone Morphogenetic Protein-, Antimicrobial Agent-, and Analgesic-Incorporated Nanofibrous Scaffolds for the Therapy of Alveolar Clefts. Pharmaceutics. 2022; 14(2):374.
https://doi.org/10.3390/pharmaceutics14020374
Chicago/Turabian Style
Chou, Pang-Yun, Demei Lee, Chi-Chang Weng, Ren-Chin Wu, Chien-Tun Liao, and Shih-Jung Liu.
2022. "Bone Morphogenetic Protein-, Antimicrobial Agent-, and Analgesic-Incorporated Nanofibrous Scaffolds for the Therapy of Alveolar Clefts" Pharmaceutics 14, no. 2: 374.
https://doi.org/10.3390/pharmaceutics14020374
APA Style
Chou, P.-Y., Lee, D., Weng, C.-C., Wu, R.-C., Liao, C.-T., & Liu, S.-J.
(2022). Bone Morphogenetic Protein-, Antimicrobial Agent-, and Analgesic-Incorporated Nanofibrous Scaffolds for the Therapy of Alveolar Clefts. Pharmaceutics, 14(2), 374.
https://doi.org/10.3390/pharmaceutics14020374
